Inicio > BIGG > Resultado de la búsqueda

    Resultados: 52

    Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy

    England. National Institute for Health and Care Excellence.
    Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults. Commercial arrangement There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...
    Inhibidores de Proteínas Quinasas/uso terapéutico, Neoplasias Pulmonares/tratamiento farmacológico, Platino (Metal)/uso terapéutico, Mutación/efectos de los fármacos, Factor de Crecimiento Epidérmico/antagonistas & inhibidores
    Texto completo

    Upadacitinib for treating moderately to severely active ulcerative colitis

    England. National Institute for Health and Care Excellence.
    Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderately to severely active ulcerative colitis in adults. Commercial arrangement There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. ...
    Colitis Ulcerosa/tratamiento farmacológico, Quinasas Janus/uso terapéutico
    Texto completo (enlace principal)     Texto completo (enlace alternativo)